AHG

NASDAQ

Akso Health Group

SectorReal EstateIndustryReal EstateIPO2017

News25/Ratings0

Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, etc. It also offers consultancy and information technology support services; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Beijing, China. As of July 13, 2021, Akso Health Group operates as a subsidiary of Webao Limited.

News · 26 weeks9-60%

2025-10-262026-04-19

Mix990d

Insider6(67%)
SEC Filings2(22%)
Other1(11%)

Latest news

25 items

17dINSIDER
SEC Form 3 filed by new insider Xie Zhongliang
3 - Akso Health Group (0001702318) (Issuer)
24dINSIDER
SEC Form 3 filed by new insider Xu Jianqiang
3 - Akso Health Group (0001702318) (Issuer)
27dINSIDER
SEC Form 3 filed by new insider Liu Wenjuan
3 - Akso Health Group (0001702318) (Issuer)
31dSEC
SEC Form 6-K filed by Akso Health Group
6-K - Akso Health Group (0001702318) (Filer)
36dINSIDER
SEC Form 3 filed by Akso Health Group
3 - Akso Health Group (0001702318) (Issuer)
36dINSIDER
SEC Form 3 filed by Akso Health Group
3 - Akso Health Group (0001702318) (Issuer)
36dINSIDER
SEC Form 3 filed by Akso Health Group
3 - Akso Health Group (0001702318) (Issuer)
72dSEC
SEC Form 6-K filed by Akso Health Group
6-K - Akso Health Group (0001702318) (Filer)
79dPR
Akso Health Group Announces Launch of Exploratory Global Patient Support Initiative
QINGDAO, China, Feb. 3, 2026 /PRNewswire/ -- Akso Health Group (NASDAQ:AHG) ("Akso Health" or the "Company") today announced the launch of the an exploratory patient support program and a strategic cooperation with Nanning Duoling Research Institute. Adopting an integrated model of "Traditional Chinese Medicine (TCM) practice + modern medical technology", certain medical resources will be coordinated and integrated to provide free in-hospital treatment plans for up to 10,000 eligible patients within participating medical institutions. The patient support program directly addresses the urgent needs of cancer patients and reconstructs the standards of medical accessibility through "global reso
252dSEC
SEC Form 20-F filed by Akso Health Group
20-F - Akso Health Group (0001702318) (Filer)
266dSEC
SEC Form NT 20-F filed by Akso Health Group
NT 20-F - Akso Health Group (0001702318) (Filer)
319dSEC
SEC Form EFFECT filed by Akso Health Group
EFFECT - Akso Health Group (0001702318) (Filer)
336dSEC
Amendment: SEC Form F-3/A filed by Akso Health Group
F-3/A - Akso Health Group (0001702318) (Filer)
357dSEC
SEC Form 6-K filed by Akso Health Group
6-K - Akso Health Group (0001702318) (Filer)
391dSEC
SEC Form 6-K filed by Akso Health Group
6-K - Akso Health Group (0001702318) (Filer)
429dPR
AHG Utilizes DeepSeek to Advance AI in Healthcare
QINGDAO, China, Feb. 18, 2025 /PRNewswire/ -- Akso Health Group (NASDAQ:AHG) (hereinafter referred to as "Akso Health," "the Company," or "we") announced today its integration of DeepSeek's advanced artificial intelligence technology. This initiative aims to further enhance AI-powered medical consultation, optimize healthcare resource allocation, and provide users with more precise and efficient medical services. The utilization of DeepSeek not only represents a significant breakthrough in the field of AI-driven healthcare but also sets a new benchmark for the industry's intelligent transformation. As an innovative medical technology company, AHG leverages DeepSeek's multimodal large-scale
472dSEC
Amendment: SEC Form F-3/A filed by Akso Health Group
F-3/A - Akso Health Group (0001702318) (Filer)
513dSEC
Amendment: SEC Form F-3/A filed by Akso Health Group
F-3/A - Akso Health Group (0001702318) (Filer)
513dSEC
SEC Form RW filed by Akso Health Group
RW - Akso Health Group (0001702318) (Filer)
518dSEC
Amendment: SEC Form F-3/A filed by Akso Health Group
F-3/A - Akso Health Group (0001702318) (Filer)
531dSEC
SEC Form 6-K filed by Akso Health Group
6-K - Akso Health Group (0001702318) (Filer)
632dSEC
SEC Form 20-F filed by Akso Health Group
20-F - Akso Health Group (0001702318) (Filer)
658dNEWS
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Qualigen Therapeutics (NASDAQ:QLGN) shares moved upwards by 42.5% to $0.25 during Thursday's regular session. The company's market cap stands at $1.5 million. The company's, Q1 earnings came out 2 days ago. Sharps Technology (NASDAQ:STSS) stock rose 33.56% to $0.31. The market value of their outstanding shares is at $6.1 million. Autonomix Medical (NASDAQ:AMIX) shares increased by 21.43% to $0.78. The market value of their outstanding shares is at $14.6 million. Akso Health Group (NASDAQ:AHG) stock rose 11.68% to $1.29. The company's market cap stands at $189.2 million. Conduit Pharmaceuticals (NASDAQ:CDT) stock rose 10.74% to $0.71. The company's market cap stands at $52.3 mill
668dSEC
SEC Form F-6 POS filed by Akso Health Group
F-6 POS - Akso Health Group (0001702318) (Subject)
686dNEWS
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Virax Biolabs Group (NASDAQ:VRAX) shares rose 88.8% to $2.02 during Thursday's regular session. The company's market cap stands at $4.7 million. FibroBiologics (NASDAQ:FBLG) shares rose 45.37% to $9.74. The market value of their outstanding shares is at $318.6 million. Aethlon Medical (NASDAQ:AEMD) stock rose 39.58% to $0.61. The company's market cap stands at $3.1 million. American Oncology Network (NASDAQ:AONC) stock rose 32.96% to $3.0. The market value of their outstanding shares is at $30.6 million. Replimune Group (NASDAQ:REPL) shares rose 29.04% to $7.17. The company's market cap stands at $440.6 million. Co-Diagnostics (NASDAQ:CODX) stock rose 27.18% to $1.31. The marke